Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Ochoa

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Clinical and Experimental Rheumatology|June 29, 2013
Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapyFernanda Genre, Raquel López-Mejías, Jose A Miranda-Filloy, et al.
Clinical and Experimental Rheumatology|August 29, 2013
Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapyFernanda Genre, Raquel López-Mejías, José A Miranda-Filloy, et al.
Annals of the Rheumatic Diseases|December 11, 2013
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patientsFernanda Genre, Raquel López-Mejías, José A Miranda-Filloy, et al.
Mediators of Inflammation|July 1, 2014
Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effectFernanda Genre, Raquel López-Mejías, Javier Rueda-Gotor, et al.
Journal of Clinical Immunology|May 16, 2015
A novel pathogenic variant in PRF1 associated with hemophagocytic lymphohistiocytosisCamilo Andrés Pérez Romero, Isaura Pilar Sánchez, Sebastian Gutierrez-Hincapié, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Clinical and Experimental Rheumatology|June 29, 2013
Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapyFernanda Genre, Raquel López-Mejías, Jose A Miranda-Filloy, et al.
Clinical and Experimental Rheumatology|August 29, 2013
Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapyFernanda Genre, Raquel López-Mejías, José A Miranda-Filloy, et al.
Annals of the Rheumatic Diseases|December 11, 2013
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patientsFernanda Genre, Raquel López-Mejías, José A Miranda-Filloy, et al.
Mediators of Inflammation|July 1, 2014
Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effectFernanda Genre, Raquel López-Mejías, Javier Rueda-Gotor, et al.
Journal of Clinical Immunology|May 16, 2015
A novel pathogenic variant in PRF1 associated with hemophagocytic lymphohistiocytosisCamilo Andrés Pérez Romero, Isaura Pilar Sánchez, Sebastian Gutierrez-Hincapié, et al.
Pageof 6